Figure 1.
SPARC expression in patients with NAFLD induced liver injury. (A) Expression of SPARC was observed on protein (immunohistochemistry) in patients with NAFLD. Magnification 100× and 400×. Patients with high hepatic SPARC mRNA expression had significantly higher serum M30 levels (B) and nominally higher RIPK3 mRNA expression (C). Data are mean ± sem, *p < 0.05. Comparison between groups was performed with Mann-Whitney U Test. mRNA expressions of SPARC and RIPK3 were significantly correlated (D). Spearman rank test.